株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の動物用寄生虫駆除剤市場動向・予測:病原生物・製品・動物種・地域別

Global Veterinary Paraciticides Market - segmented by disease causing organisms, By products, By animal types & by Geography - Trends & Forecasts 2016- 2021.

発行 Mordor Intelligence LLP 商品コード 319397
出版日 ページ情報 英文 190 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界の動物用寄生虫駆除剤市場動向・予測:病原生物・製品・動物種・地域別 Global Veterinary Paraciticides Market - segmented by disease causing organisms, By products, By animal types & by Geography - Trends & Forecasts 2016- 2021.
出版日: 2016年08月01日 ページ情報: 英文 190 Pages
概要

世界の動物用寄生虫駆除剤市場は2014年から2020年の間に6.0%のCAGRで拡大し、市場額は2014年の289億米ドルから2020年までに397億米ドルに達すると予測されています。

当レポートでは、世界の動物用寄生虫駆除剤市場について、病原生物、製品、動物種および地域別に調査分析し、市場の現況と将来の予測、包括的な競合情勢の分析、および主要企業の市場シェアや近年の発展動向を含む詳細情報などを提供しています。

第1章 イントロダクション

第2章 市場分析

  • 市販の動物薬
  • 獣医学vs.人間の医学

第3章 市場力学

  • 市場促進因子
  • 市場抑制因子
  • ポーターのファイブフォース分析

第4章 世界の動物用寄生虫駆除剤市場区分

  • 世界の動物用寄生虫駆除剤市場:病原生物別
    • イントロダクション
    • 外部寄生虫駆除剤
      • ノミ
      • シラミ
      • ダニ
    • 内部寄生虫駆除剤
      • 胃腸管線虫
      • 犬糸状虫
      • 肺線虫
  • 世界の動物用寄生虫駆除剤市場:製品別
    • 経口液体
    • タブレット
    • 注射剤
    • スプレー
    • プアオン
    • スポットオン(滴下)
    • カラ―
    • イヤータグ
  • 世界の動物用寄生虫駆除剤市場:種類別
    • コンパニオンアニマル
      • イヌ
      • ネコ
    • 家畜
  • 世界の動物用寄生虫駆除剤市場:地域別
    • 北米
    • 欧州
    • アジア太平洋

第5章 競合情勢

  • 市場の主要企業
  • M&A
  • 新製品発売
  • 合意、協力および提携

第6章 企業プロファイル

  • Zoetis animal healthcare
    • 財務概要
    • 事業概要
    • 事業戦略
  • Merck
  • Merial (Sanofiの動物保健部門)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The global veterinary parasiticides market was valued at USD 2,714 million in 2014 and is projected to reach USD 5,121million by 2020, at a CAGR of 11.16% during the forecast period from 2014 to 2019.

Global Veterinary Parasiticides Market- Market Dynamics

Veterinary pharmaceuticals, including parasiticides, have transformed the health of companion and livestock animals across the globe over the past two decades. Today, the spectrum of parasiticides for veterinary applications continues to expand with a variety of ectoparasiticides, endoparasiticides, and endectocides that are launched every year. Constant innovations are leading to the emergence of novel parasiticide delivery systems as well in this market.

Drivers

Some of the key factors driving the market towards growth are:

  • Increase in pet ownership
  • Improved nutrition
  • Intensifying consumer focus on food safety
  • Greater livestock production rates
  • Increasing food-borne diseases

Restraints

Some of the factors restraining the market are:

  • Scarcity of arable land and water
  • Increased competition for cultivated land
  • Increased competition for cost-effective production

The global veterinary parasiticides market can be segmented on the basis of disease-causing organisms into Ectoparasiticides (fleas, lice, mites) and Endoparasiticides (gastrointestinal nematode, heartworms, lungworms). By products, the market can be segmented into oral liquids, tablets, injectables, sprays, pour on, spot on, collars, and ear tags. By species, the market can be further classified into companion animals (dogs, cats, horses, and others) and farm animals (cattle, swine, poultry, fish, and sheep). Lastly, by geography, the market can be divided into North America (US, Canada, Mexico), Europe (France, Italy, Germany, Spain, Sweden, Rest of Europe), and Asia-Pacific (China, Japan, India, Rest of Asia-Pacific).

Some of the key players in the market are:

  • Bayer Healthcare
  • Boehringer Ingelheim
  • Ceva Animal Health, Inc.
  • Elanco
  • Merck
  • Merial (Animal Health Division of Sanofi)

Key Deliverables in the Study

  • Market analysis for the veterinary parasiticides market, with region specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market share.
  • Identification and analysis of the macro and micro factors that affect the veterinary parasiticides market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.

Table of Contents

1. INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Recent Trends

2. Market Analysis

  • 2.1. Market Animal Health Products
  • 2.2. Animal medicines vs. human Medicines

3. Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increase in pet ownership
    • 3.1.2. Improved Nutrition
    • 3.1.3. Intensifying consumer focus on food safety
    • 3.1.4. Greater Livestock production
    • 3.1.5. Increasing Zoonotic and Foodborne Diseases
  • 3.2. Market Constraints
    • 3.2.1. Scarcity of arable land and water
    • 3.2.2. Increased competition for cultivated land
    • 3.3.3. Cost-effective production
  • 3.3. Porter's Five Force Analysis
    • 3.3.1. Threat of New Entrant
    • 3.3.2. Internal Rivalry
    • 3.3.3. Buyer bargaining power
    • 3.3.4. Supplier bargaining power
    • 3.3.5. Threat of substitutes

4.Global veterinary parasiticides market Segmentation

  • 4.1. Global veterinary Parasiticides Market, By disease causing organisms
    • 4.1.1. Introduction
    • 4.1.2. Ectoparasiticides
      • 4.1.2.1. Fleas
      • 4.1.2.1. Lice
      • 4.1.2.1. Mites
    • 4.1.3. Endoparasiticides
      • 4.1.3.1. Gastrointestinal nematode
      • 4.1.3.2. Heartworms
      • 4.1.3.3. Lungworms
  • 4.2. Global veterinary Parasiticides Market, By products
    • 4.2.1. Oral Liquids
    • 4.2.2. Tablets
    • 4.2.3. Injectables
    • 4.2.4. Sprays
    • 4.2.5. Pour On
    • 4.2.6. Spot On
    • 4.2.7. Collars
    • 4.2.8. Ear Tags
  • 4.3. Global veterinary Parasiticides Market, By species
    • 4.3.1. Companion Animals
      • 4.3.1.1. Dogs
      • 4.3.1.2. Cats
      • 4.3.1.3. Horses
    • 4.3.2. Farm animal
      • 4.3.2.1. Cattle
      • 4.3.2.2. Swine
      • 4.3.2.3. Poultry
      • 4.3.2.4. Fish
      • 4.3.2.5. Sheep
  • 4.4. .Global Veterinary Market Segmentation, By Geography
    • 4.4.1. North America
      • 4.4.1.1. US
      • 4.4.1.2. Mexico
      • 4.4.1.3. Canada
    • 4.4.2. Europe
      • 4.4.2.1. France
      • 4.4.2.2. Italy
      • 4.4.2.3. Germany
      • 4.4.2.4. Spain
      • 4.4.2.5. Sweden
      • 4.4.2.6. Rest of Europe
    • 4.4.3. Asia-Pacific
      • 4.4.3.1. India
      • 4.4.3.2. China
      • 4.4.3.3. Japan
      • 4.4.3.4. Rest of Asia-Pacific

5. Competitive landscape

  • 5.1. Major players in the market
  • 5.2. Mergers and acquisitions
  • 5.3. New product launches
  • 5.4. Agreement, Collaborations, and Partnerships
  • 5.5. Recommendations for New players in the market
  • 5.6. Recommendations for Existing players in the market

6. Company profiles

  • 6.1. Zoetis animal healthcare
    • 6.1.1. Financial Overview
    • 6.1.2. Business overview
    • 6.1.3. Business strategies
  • 6.2. Merck
    • 6.2.1. Financial Overview
    • 6.2.2. Business overview
    • 6.2.3. Business strategies
  • 6.3. Merial (Animal Health Division Of Sanofi)
    • 6.3.1. Financial Overview
    • 6.3.2. Business overview
    • 6.3.3. Business strategies
  • 6.4. Elanco
    • 6.4.1. Financial Overview
    • 6.4.2. Business overview
    • 6.4.3. Business strategies
  • 6.5. Bayer healthcare
    • 6.5.1. Financial Overview
    • 6.5.2. Business overview
    • 6.5.3. Business strategies
  • 6.6. Ceva Animal Health, Inc.
    • 6.6.1. Financial Overview
    • 6.6.2. Business overview
    • 6.6.3. Business strategies
  • 6.7. Virbac
    • 6.7.1. Financial Overview
    • 6.7.2. Business overview
    • 6.7.3. Business strategies
  • 6.8. Boehringer Ingelheim
    • 6.8.1. Financial Overview
    • 6.8.2. Business overview
    • 6.8.3. Business strategies

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Sources
  • 7.3. Bibliography
  • 7.4. Disclaimer
Back to Top